RECRUITINGOBSERVATIONAL
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
About This Trial
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patient received IV Artesunate
- Patient was pregnant while receiving IV Artesunate
- Patient was at least 15 years of age
- Patient or legal guardian/representative gave consent for the study and to collect data from her physicians
Exclusion Criteria
• None
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patient received IV Artesunate
* Patient was pregnant while receiving IV Artesunate
* Patient was at least 15 years of age
* Patient or legal guardian/representative gave consent for the study and to collect data from her physicians
Exclusion Criteria
• None
Locations (1)
4C Pharma Solutions
Piscataway, New Jersey, United States